Clinical trial
A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given…
NCT00381732 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00381732 |
|---|---|
| Title | A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction |
| Official title | A Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil (2.5mg and 5mg) Administered Once Daily to Men With Erectile Dysfunction |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | ICOS Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | tadalafil, placebo |
| Enrollment | 280 |
| Start date | Oct 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Sep 28, 2006 |
| Last update posted | Nov 7, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: